Company Data
Biomea Fusion Inc.
Ticker
BMEA
Current Price
$1.28 1.59%
Market Cap
$92.5M
Price Target
Refer to Report
Volume
523.9K
52wk Range
$0.8719 - $2.99
Overview
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company’s lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.